Healthcare provider profile · identity verified

Elliot Galey, MD

Family Practice · BETTENDORF, IA · NPI 1811317282

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	667	177
Losartan Potassium	Losartan Potassium	428	114
Lisinopril	Lisinopril	364	100
Levothyroxine Sodium	Levothyroxine Sodium	330	80
Amlodipine Besylate	Amlodipine Besylate	291	80
Rosuvastatin Calcium	Rosuvastatin Calcium	287	87
Hydrochlorothiazide	Hydrochlorothiazide	259	73
Simvastatin	Simvastatin	227	60
Omeprazole	Omeprazole	200	61
Sertraline Hcl	Sertraline Hcl	184	47
Metoprolol Succinate	Metoprolol Succinate	171	48
Alendronate Sodium	Alendronate Sodium	168	50
Metformin Hcl	Metformin Hcl	157	41
Atenolol	Atenolol	148	38
Pantoprazole Sodium	Pantoprazole Sodium	143	40
Metformin Hcl Er	Metformin Hcl	120	32
Tamsulosin Hcl	Tamsulosin Hcl	106	30
Gabapentin	Gabapentin	103	34
Potassium Chloride	Potassium Chloride	102	27
Famotidine	Famotidine	100	27
Metoprolol Tartrate	Metoprolol Tartrate	93	25
Escitalopram Oxalate	Escitalopram Oxalate	85	23
Furosemide	Furosemide	84	26
Fluoxetine Hcl	Fluoxetine Hcl	82	23
Zolpidem Tartrate	Zolpidem Tartrate	75	17
Alprazolam	Alprazolam	74	26
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	72	19
Ozempic	Semaglutide	70	12
Montelukast Sodium	Montelukast Sodium	68	17
Allopurinol	Allopurinol	67	20
Albuterol Sulfate Hfa	Albuterol Sulfate	66	23
Warfarin Sodium	Warfarin Sodium	66	11
Trazodone Hcl	Trazodone Hcl	63	19
Pravastatin Sodium	Pravastatin Sodium	61	16
Duloxetine Hcl	Duloxetine Hcl	60	16
Lovastatin	Lovastatin	60	17
Spironolactone	Spironolactone	60	17
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	59	16
Fluticasone Propionate	Fluticasone Propionate	57	21
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	57	13
Januvia	Sitagliptin Phosphate	57	11
Bupropion Xl	Bupropion Hcl	56	16
Donepezil Hcl	Donepezil Hcl	53	12
Chlorthalidone	Chlorthalidone	51	16
Citalopram Hbr	Citalopram Hydrobromide	51	15
Eliquis	Apixaban	51	15
Pioglitazone Hcl	Pioglitazone Hcl	51	13
Jardiance	Empagliflozin	50	15
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	45	12
Ezetimibe	Ezetimibe	44	13
Triamcinolone Acetonide	Triamcinolone Acetonide	44	25
Glipizide	Glipizide	40	11
Meloxicam	Meloxicam	40	13
Finasteride	Finasteride	38	suppressed
Irbesartan	Irbesartan	35	suppressed
Nifedipine Er	Nifedipine	35	suppressed
Tresiba Flextouch U-100	Insulin Degludec	35	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	34	12
Venlafaxine Hcl Er	Venlafaxine Hcl	33	suppressed
Cephalexin	Cephalexin	30	24
Glimepiride	Glimepiride	29	suppressed
Mounjaro	Tirzepatide	29	suppressed
Pregabalin	Pregabalin	29	suppressed
Xarelto	Rivaroxaban	28	suppressed
Propranolol Hcl	Propranolol Hcl	27	suppressed
Tramadol Hcl	Tramadol Hcl	27	suppressed
Azelastine Hcl	Azelastine Hcl	26	suppressed
Clopidogrel	Clopidogrel Bisulfate	26	suppressed
Terazosin Hcl	Terazosin Hcl	26	suppressed
Prednisone	Prednisone	25	20
Solifenacin Succinate	Solifenacin Succinate	25	suppressed
Bupropion Hcl Sr	Bupropion Hcl	24	suppressed
Arnuity Ellipta	Fluticasone Furoate	23	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	23	suppressed
Enalapril Maleate	Enalapril Maleate	23	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	22	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	21	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	21	19
Baclofen	Baclofen	21	suppressed
Trulicity	Dulaglutide	21	suppressed
Carvedilol	Carvedilol	20	suppressed
Indapamide	Indapamide	20	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	20	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	19	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	19	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	19	suppressed
Nystatin	Nystatin	18	12
Ropinirole Hcl	Ropinirole Hcl	18	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	18	suppressed
Amoxicillin	Amoxicillin	17	suppressed
Doxepin Hcl	Doxepin Hcl	17	suppressed
Mirtazapine	Mirtazapine	17	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	17	suppressed
Ondansetron Hcl	Ondansetron Hcl	16	suppressed
Clonazepam	Clonazepam	15	suppressed
Ketoconazole	Ketoconazole	15	suppressed
Naproxen	Naproxen	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	14
Tizanidine Hcl	Tizanidine Hcl	15	suppressed
Estradiol	Estradiol	14	suppressed
Novolog Flexpen	Insulin Aspart	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	13	suppressed
Azithromycin	Azithromycin	13	12
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	13	suppressed
Ramipril	Ramipril	13	suppressed
Rybelsus	Semaglutide	13	suppressed
Synthroid	Levothyroxine Sodium	13	suppressed
Telmisartan	Telmisartan	13	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	12	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	12	12
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Prazosin Hcl	Prazosin Hcl	12	suppressed
Primidone	Primidone	12	suppressed
Qvar Redihaler	Beclomethasone Dipropionate	12	suppressed
Ventolin Hfa	Albuterol Sulfate	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Buspirone Hcl	Buspirone Hcl	11	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	11	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Memantine Hcl	Memantine Hcl	11	suppressed
Verapamil Sr	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error